InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (4 ops.)
Explore the full record of transactions filed by Hambleton Julie, Director. Insider active across 4 companies, notably SpringWorks Therapeutics, Inc.. Aggregated, 9 reports have been published. Total volume traded: €561k. The latest transaction was filed on 19 May 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
04,818 shares0
Common Stock
SEC:0001104659-22-063506:0·
€68,1521,000 shares@ €68.15234.2% of flow
Common Stock
SEC:0001209191-21-051011·
€68,1521,000 shares@ €68.15217.1% of flow
Common Stock
SEC:0001209191-21-051011:0·
€81,4666,000 shares@ €13.5776100.0% of flow
Common Stock
SEC:0000899243-21-029053·
Ideal exit: 16 Apr 2022 (T+270)
€81,4666,000 shares@ €13.57760.0026% mcap50.0% of flow
Common Stock
SEC:0000899243-21-029053:0·
Ideal exit: 16 Apr 2022 (T+270)
€130,9572,000 shares@ €65.478465.8% of flow
Common Stock
SEC:0001209191-21-038002·
€130,9572,000 shares@ €65.478432.9% of flow
Common Stock
SEC:0001209191-21-038002:0·
01,106 shares0
Common Stock
SEC:0001104659-21-070518·
01,106 shares0
Common Stock
SEC:0001104659-21-070518:0·
9 of 9 declarations
About Hambleton Julie
Julie Hambleton is a Board Member at SpringWorks Therapeutics, Inc. and IGM Biosciences, Inc. She contributes to the governance of these biopharmaceutical companies by participating in strategic decision-making. Her experience in the biotechnology sector is valuable in guiding their development.
